Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Base-Editing Enzyme APOBEC3A Catalyzes Cytosine Deamination in RNA with Low Proficiency and High Selectivity. | ACS Chem Biol | 2022 | 35262324 | PubTator, text mining | PubMed |
| APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival. | Am J Cancer Res | 2022 | 35261799 | PubTator, text mining | PubMed |
| Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. | Nat Rev Genet | 2022 | 35256818 | PubTator, text mining | PubMed |
| Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism. | J Mol Med (Berl) | 2022 | 35247068 | PubTator, text mining | PubMed |
| Landscape of adenosine-to-inosine RNA recoding across human tissues. | Nat Commun | 2022 | 35246538 | PubTator, text mining | PubMed |
| lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells. | Mol Ther Nucleic Acids | 2022 | 35228900 | PubTator, text mining | PubMed |
| Synergistic Effects of Toll-Like Receptor 1/2 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages. | Front Cell Dev Biol | 2022 | 35223841 | PubTator, text mining | PubMed |
| Analysis of airline employees' perceptions of corporate preparedness for COVID-19 disruptions to airline operations. | Transp Policy (Oxf) | 2022 | 35221549 | PubTator, text mining | PubMed |
| Metastasising Fibroblasts Show an HDAC6-Dependent Increase in Migration Speed and Loss of Directionality Linked to Major Changes in the Vimentin Interactome. | Int J Mol Sci | 2022 | 35216078 | PubTator, text mining | PubMed |
| Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System. | Viruses | 2022 | 35215970 | PubTator, text mining | PubMed |
| Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis. | Mol Biol | 2022 | 35194245 | PubTator, text mining | PubMed |
| Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer. | Oncogene | 2022 | 35194151 | PubTator, text mining | PubMed |
| ISG20: an enigmatic antiviral RNase targeting multiple viruses. | FEBS Open Bio | 2022 | 35174977 | PubTator, text mining | PubMed |
| Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions. | Semin Oncol | 2022 | 35168813 | PubTator, text mining | PubMed |
| In Vivo Rapid Investigation of CRISPR-Based Base Editing Components in Escherichia coli (IRI-CCE): A Platform for Evaluating Base Editing Tools and Their Components. | Int J Mol Sci | 2022 | 35163069 | PubTator, text mining | PubMed |
| Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. | Front Immunol | 2022 | 35154157 | PubTator, text mining | PubMed |
| Regulation of antiviral innate immunity by chemical modification of viral RNA. | Wiley Interdiscip Rev RNA | 2022 | 35150188 | PubTator, text mining | PubMed |
| Biallelic mutations in cancer genomes reveal local mutational determinants. | Nat Genet | 2022 | 35145300 | PubTator, text mining | PubMed |
| Somatic mutational profiles and germline polygenic risk scores in human cancer. | Genome Med | 2022 | 35144655 | PubTator, text mining | PubMed |
| Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. | Nature | 2022 | 35140399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=30